Drug

Elmiron

Elmiron is the only oral medication approved by the U.S. Food and Drug Administration to treat interstitial cystitis, a painful bladder condition affecting mostly women. In recent years, studies have found an association between long-term Elmiron use and a serious eye condition known as pigmentary maculopathy. While there are other types of maculopathies, such as macular degeneration, pigmentary maculopathy (also known as PPS maculopathy) is uniquely associated with Elmiron. 

In June 2020, manufacturer Janssen Pharmaceuticals added a warning regarding the risk of pigmentary maculopathy. 

Elmiron is also associated with a wide range of other side effects.

Introduced

1996

Treats

Chronic bladder pain

Side Effects

Long-term users of Elmiron have suffered a variety of side effects including a type of retina damage that could lead to permanent blindness if left untreated.

Read more about Elmiron

Image of a person's eye representing the elmiron diagnostic test.

Elmiron Bladder Medication and Vision Lo...

Risa Kerslake · September 23, 2020

Symptoms that have been reported include blurry vision, difficulty seeing in the dark, and, in advanced stages, blind spots. 

Health Features